Archive 1995–2023
2009, volume 25, issue 3-4
Only for Pharmacotherapy in Psychiatry and Neurology
Omega-3 polyunsaturated fatty acids: biochemical, functional and practical aspects
Jerzy Z. Nowak
Farmakoterapia w Psychiatrii i Neurologii, 2009, 3-4, 127–146
Original article
Depressive symptoms in the first episode of schizophrenia – analysis of Polish results of the EUFEST Study
Tomasz Szafrański, Jerzy Samochowiec, Marcin Olajossy, Jolanta Rabe-Jabłońska, Janusz Rybakowski
Farmakoterapia w Psychiatrii i Neurologii, 2009, 3-4, 147–154
Original article
Prolactin concentration in Polish patients with the first episode of schizophrenia participating in the EUFEST
Janusz Rybakowski, Jolanta Formanowicz, Marcin Olajossy, Jerzy Samochowiec
Farmakoterapia w Psychiatrii i Neurologii, 2009, 3-4, 155–159
Original article
Comparison of therapeutical results: pharmacotherapy and ECT in patients with drug-resistant depression
Robert T. Hese, Jarosław Sobiś, Tomasz Zyss, Piotr Gorczyca, Jerzy Matysiakiewicz, Robert Pudlo, Magdalena Jarząb
Farmakoterapia w Psychiatrii i Neurologii, 2009, 3-4, 161–165
Review article
Fourty six years of lithium in prevention of recurrences of bipolar affective illness
Sebastian Kliwicki, Janusz Rybakowski
Farmakoterapia w Psychiatrii i Neurologii, 2009, 3-4, 167–172
Review article
Two faces of GABA: inhibition and excitation
Wojciech Kostowski, Anna Witanowska
Farmakoterapia w Psychiatrii i Neurologii, 2009, 3-4, 173–178
Review article
NMDA receptor insufficiency in pathogenesis of schizophrenia
Marek Krzystanek, Artur Pałasz, Ewa Krzystanek, Irena Krupka-Matuszczyk
Farmakoterapia w Psychiatrii i Neurologii, 2009, 3-4, 179–190
Review article
Copper – involving in neurodegeneration: from molecular mechanisms to therapeutic strategy
Magdalena Rudnicka
Farmakoterapia w Psychiatrii i Neurologii, 2009, 3-4, 191–197